Article info

Download PDFPDF
Morbidity of Surgery After Neoadjuvant Chemotherapy Including Bevacizumab for Advanced Ovarian Cancer

Authors

  1. Address correspondence and reprint requests to Elisabeth Chéreau, MD, Service de Chirurgie Oncologique, Institut Paoli Calmettes, 232, bd Sainte Marguerite, 13009 Marseille. E-mail: chereaue{at}ipc.unicancer.fr.

Citation

Chéreau E, Lambaudie E, Houvenaeghel G
Morbidity of Surgery After Neoadjuvant Chemotherapy Including Bevacizumab for Advanced Ovarian Cancer

Publication history

  • Received April 12, 2013
  • Accepted May 28, 2013
  • First published September 1, 2013.
Online issue publication 
September 01, 2013

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.